Bigbear Pharmaceutical·Medication Guide

• FDA Expands Revlimid Indication to Include First-Line Treatment for Newly Diagnosed Multiple Myeloma

  Regulatory Expansion into Frontline TherapyOn February 18, 2015, Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has ex···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 150

• FDA Approves Revlimid as the First Oral Therapy for Relapsed or Refractory Mantle Cell Lymp

  Regulatory Approval for Advanced Mantle Cell LymphomaOn June 5, 2013, Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) a···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 142

• FDA Approval of Darzalex Combination Therapies for Multiple Myeloma Patients After Prior Treatment

  Expanded Indication for Darzalex in Relapsed or Refractory Multiple MyelomaOn November 21, 2016, Janssen Biotech, Inc. announced that the U.S. Food an···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 147

• FDA Expands Revlimid Indication to Include Maintenance Therapy Following Auto-HSCT in Multiple Myelo

  Strategic Expansion of Revlimid Maintenance TherapyOn February 22, 2017, Celgene Corporation announced that the U.S. Food and Drug Administration (FDA···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 139

• FDA Approval of Revlimid and Rituximab Combination for Previously Treated Follicular and Ma

  Overview of EltrombopagEltrombopag is an oral non-peptide thrombopoietin receptor agonist (TPO-RA). It increases platelet production by activating the···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 152

• FDA Approval of Darzalex Combination Therapy for Newly Diagnosed, Transplant-Ineligible Multiple Mye

  Regulatory Milestone and Expanded Treatment IndicationOn June 27, 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that t···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 145

• FDA Approval of Pfizer’s Adcetris Combination for Relapsed/Refractory DLBCL

  Regulatory Milestone for Pfizer’s Oncology PortfolioOn February 12, 2025, Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 144

• Drug Interactions and Special Population Considerations for Eltrombopag

  Overview of EltrombopagEltrombopag is an oral non-peptide thrombopoietin receptor agonist (TPO-RA). It increases platelet production by activating the···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 134

• Important Considerations for Avatrombopag Ethanolamine Tablets: Drug Interactions and Special Popula

  Use in Special PopulationsPregnant WomenAnimal studies indicate that this product may have potential effects on the fetus. Pregnant women should use i···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 141

• Drug Interactions and Special Population Considerations for Eltrombopag

  Overview of EltrombopagEltrombopag is an oral non-peptide thrombopoietin receptor agonist (TPO-RA). It increases platelet production by activating the···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 138

• What Is Eltrombopag Used For

  Overview of EltrombopagEltrombopag is an oral thrombopoietin receptor agonist, primarily indicated for the treatment of chronic immune thrombocytopeni···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 140

• Drug Interactions and Special Population Considerations for Lenalidomide

  Contraindicated Populations for LenalidomidePregnant women are contraindicated.Women of childbearing potential who do not fully meet contraceptive req···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 134

• What Is Lenalidomide Used For

  Mechanism of Action and Therapeutic EffectsLenalidomide is an analog of thalidomide. Although its precise mechanism of action is not fully understood,···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 131

• What other drugs may affect capmatinib?

  Certain medications should not be used together due to safety concerns. Some drugs may alter the blood levels of other medications you are taking, whi···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 135

• What should I avoid while taking capmatinib?

  Capmatinib may make your skin more sensitive to sunlight, increasing the risk of sunburn. Avoid prolonged exposure to sunlight and tanning beds. Wear ···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 128